4.5 Review

CRISPR/Cas based gene editing: marking a new era in medical science

期刊

MOLECULAR BIOLOGY REPORTS
卷 48, 期 5, 页码 4879-4895

出版社

SPRINGER
DOI: 10.1007/s11033-021-06479-7

关键词

Programmable nucleases; CRISPR; Cas9; Gene therapy; Gene editing

资金

  1. EMR Grant (Science and Engineering Research Board (SERB), New Delhi, India) [EMR/2017/004363]
  2. ICMR Grant (Indian Council of Medical Research, New Delhi, India) [2019-0916/SCR/ADHOC_BMS]
  3. Council of Scientific and Industrial Research (CSIR), India

向作者/读者索取更多资源

CRISPR/Cas9 system, developed from bacterial adaptive immune system, has revolutionized genome engineering and made gene therapy closer to reality. Its rapid evolution from double strand breaks to advanced gene regulation applications has greatly benefited medical science.
CRISPR/Cas9 system, a bacterial adaptive immune system developed into a genome editing technology, has emerged as a powerful tool revolutionising genome engineering in all branches of biological science including agriculture, research and medicine. Rapid evolution of CRISPR/Cas9 system from the generation of double strand breaks to more advanced applications on gene regulation has made the wide-spread use of this technology possible. Medical science has benefited greatly from CRISPR/Cas9; being both a versatile and economical tool, it has brought gene therapy closer to reality. In this review, the development of CRISPR/Cas9 system, variants thereof and its application in different walks of medical science- research, diagnostics and therapy, will be discussed.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据